PROCEPT BioRobotics Corpo... (PRCT)
NASDAQ: PRCT
· Real-Time Price · USD
41.59
1.47 (3.66%)
At close: Aug 15, 2025, 3:59 PM
42.00
1.00%
After-hours: Aug 15, 2025, 07:57 PM EDT
PROCEPT BioRobotics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -90.19M | -91.41M | -100.06M | -103.71M | -103.37M | -105.9M | -106.56M | -104.56M | -98.45M | -87.15M | -77.33M | -68.82M | -64.22M | -59.85M | -56.78M | -54.69M | -52.98M |
Depreciation & Amortization | 5.53M | 5.23M | 5.1M | 4.83M | 4.2M | 3.81M | 3.15M | 2.8M | 2.88M | 2.84M | 2.94M | 3.03M | 3.17M | 3.32M | 3.28M | 3.19M | 3.06M |
Stock-Based Compensation | 35.69M | 31.84M | 27.74M | 24.55M | 21.67M | 19.13M | 17.04M | 14.94M | 12.51M | 10.34M | 8.95M | 6.65M | 4.7M | 3.8M | 2.9M | 2.54M | 2.32M |
Other Working Capital | 4.49M | 13.02M | 13.16M | 11.24M | 13.13M | 10.9M | 13.4M | 16.57M | 12.92M | 10.61M | 8.7M | 4.53M | 2.56M | 3.52M | 3.61M | 3.03M | 2.09M |
Other Non-Cash Items | 18.83M | 18.23M | 29.57M | 33.56M | 16.73M | 17.57M | 9.58M | 5.77M | 5.89M | 5.08M | 749K | -306K | -326K | -345K | -264K | -249K | -665.5K |
Deferred Income Tax | n/a | n/a | -12.31M | -16.67M | -16.46M | -16.46M | -4.15M | 213K | n/a | n/a | 149K | -44K | 731K | 451K | 911K | 787K | -233K |
Change in Working Capital | -37.95M | -47.33M | -25.87M | -18.53M | -27.15M | -26.16M | -27.44M | -28.45M | -20.9M | -11.49M | -7.14M | -5.1M | -4.42M | -4.71M | -4.35M | -4.09M | -3.32M |
Operating Cash Flow | -83.91M | -99.21M | -91.61M | -91.76M | -104.36M | -108M | -108.38M | -109.29M | -98.08M | -80.38M | -71.68M | -64.58M | -60.37M | -57.33M | -54.3M | -52.5M | -51.57M |
Capital Expenditures | -4.3M | -4.41M | -11.95M | -17.48M | -21.81M | -25.21M | -17.36M | -13.09M | -7.94M | -2.65M | -2.12M | -716K | -608K | -592K | -269K | -178K | -170K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -4.3M | -4.41M | -11.95M | -17.48M | -21.81M | -25.21M | -17.36M | -13.09M | -7.94M | -2.65M | -2.12M | -716K | -608K | -592K | -269K | -178K | -170K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 3.61M | 3.61M | 3.61M | 3.61M | 2.41M | 2.41M | 2.41M | 2.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.3M | 7.88M | 10.75M | 172.87M | 170M | 167.79M | 162.12M | 782K | 1.21M | 2.13M | 5.62M | 178.96M | 262.23M | 262.16M | 261.71M | 90.34M | 17.86M |
Financial Cash Flow | 178.84M | 180.13M | 12.46M | 172.87M | 170M | 167.79M | 163.61M | 2.27M | 2.7M | 3.61M | 5.57M | 178.92M | 262.18M | 262.12M | 261.71M | 166.82M | 94.35M |
Net Cash Flow | 90.63M | 76.5M | -91.1M | 63.63M | 43.83M | 34.59M | 37.87M | -120.11M | -103.31M | -79.42M | -68.23M | 113.62M | 201.21M | 204.19M | 207.14M | 114.15M | 86.89M |
Free Cash Flow | -88.21M | -103.62M | -103.56M | -109.24M | -126.17M | -133.21M | -125.74M | -122.38M | -106.02M | -83.03M | -73.8M | -65.3M | -60.98M | -57.93M | -54.57M | -52.68M | -51.74M |